Safety Alert - Baraclude, entecavir tablets and oral solution
AIDS (Acquired Immunodeficiency Syndrome or Acquired Immune Deficiency Syndrome, sometimes written Aids) is a human disease characterized by progressive destruction of the body's immune system. It is widely accepted that AIDS results from infection with HIV (Human Immunodeficiency Virus).
logo - spiritindia - Safety Alert - Baraclude, entecavir tablets and oral solution
Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT

Safety Alert - Baraclude, entecavir tablets and oral solution

HIV :: Safety Alert - Baraclude, entecavir tablets and oral solution

HIV :: Safety Alert - Baraclude, entecavir tablets and oral solution

Healthcare professionals are advised that when considering therapy with Baraclude in an HIV/HBV co-infected patient not receiving HAART, the risk of developing HIV resistance cannot be excluded based on current information.

FDA and Bristol-Myers Squibb notified healthcare professionals of revisions to the MICROBIOLOGY/Antiviral Activity and INDICATIONS AND USAGE/Description of Clinical Studies/Special Populations sections of the prescribing information for Baraclude. The revised labeling is the result of a case report in which a human immunodeficiency virus (HIV) variant containing the M184V resistance substitution was documented during Baraclude treatment for chronic hepatitis B virus (HBV) infection in an HIV/HBV co-infected patient who was not simultaneously receiving highly active antiretroviral therapy (HAART).

Current treatment guidelines recommend Baraclude as an option for treatment of HBV in the HIV/HBV co-infected adult patient who does not qualify for HAART. Healthcare professionals are advised that when considering therapy with Baraclude in an HIV/HBV co-infected patient not receiving HAART, the risk of developing HIV resistance cannot be excluded based on current information.

(HIV :: Safety Alert - Baraclude, entecavir tablets and oral solution published at SpiritIndia on Sunday, February 25, 2007)

Search more information on HIV

Recently posted related articles on HIV :

  1. HIV :: A hairpin to fight HIV
  2. HIV :: Testing delays cause severe AIDS complications, Einstein researchers find
  3. HIV :: HIV-TB spreads in Africa, undermines control of world's 2 deadliest infectious diseases
  4. HIV :: HIV patients sicker when seeking care than in the past
  5. HIV :: UN refugee agency launches HIV/AIDS awareness project in Nepal
  6. HIV :: A low prevalence of H pylori in HIV-positive patients
  7. HIV :: HIV linked to increased risk of ESRD in African-Americans
  8. HIV :: FDA approves new HIV drug raltegravir tablets
  9. HIV :: Many Africans don't continue HIV AIDS treatment
  10. HIV :: FDA approves Merck's Isentress, raltegravir tablets for HIV AIDS

»»   Anemia :: Roche suspends enrollment for anemia drug trial
««   Alcohol :: Skills training program can reduce alcohol consumption

Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com